Spotlights on adult patients with pediatric-type diffuse gliomas in accordance with the 2021 WHO classification of CNS tumors

Spotlights on adult patients with pediatric-type diffuse gliomas in accordance with the 2021 WHO classification of CNS tumors

IntroductionThe fifth edition of the World Health Organization (WHO) classification of central nervous system (CNS) tumors released in 2021 formally defines pediatric-type diffuse gliomas. However, there is still little understanding of pediatric-type diffuse gliomas, and even less attention has bee...

Full description

Bibliographic Details
Main Authors:	Wenlin Chen, Shanmu Jin, Qianshu Liu, Hai Wang, Yu Xia, Xiaopeng Guo, Siying Guo, Yaning Wang, Yixin Shi, Delin Liu, Yilin Li, Yuekun Wang, Hao Xing, Junlin Li, Jiaming Wu, Tingyu Liang, Tian Qu, Huanzhang Li, Tianrui Yang, Kun Zhang, Yu Wang, Wenbin Ma
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-05-01
Series:	Frontiers in Neuroscience
Subjects:	glioma 2021 WHO classification of central nervous system tumors pediatric-type diffuse gliomas adult patients molecular pathology
Online Access:	https://www.frontiersin.org/articles/10.3389/fnins.2023.1144559/full

Similar Items

Clinical updates on gliomas and implications of the 5th edition of the WHO classification of central nervous system tumors
by: Xiaopeng Guo, et al.
Published: (2023-03-01)

Clinical roles of EGFR amplification in diffuse gliomas: a real-world study using the 2021 WHO classification of CNS tumors
by: Hai Wang, et al.
Published: (2024-02-01)

Novel insight into histological and molecular astrocytoma, IDH‐mutant, Grade 4 by the updated WHO classification of central nervous system tumors
by: Wenlin Chen, et al.
Published: (2023-09-01)

A prognostic model for overall survival in recurrent glioma patients treated with bevacizumab-containing therapy
by: Shanmu Jin, et al.
Published: (2024-03-01)

An online survival predictor in glioma patients using machine learning based on WHO CNS5 data
by: Liguo Ye, et al.
Published: (2023-05-01)

Histological and molecular glioblastoma, IDH-wildtype: a real-world landscape using the 2021 WHO classification of central nervous system tumors
by: Xiaopeng Guo, et al.
Published: (2023-07-01)

Prognostic Value of Choline and Other Metabolites Measured Using <sup>1</sup>H-Magnetic Resonance Spectroscopy in Gliomas: A Meta-Analysis and Systemic Review
by: Yixin Shi, et al.
Published: (2022-12-01)

Annual Research Progress of Glioma in China in 2021
by: CHEN Wenlin, et al.
Published: (2022-09-01)

Characteristic analysis and identification of novel molecular biomarkers in elderly glioblastoma patients using the 2021 WHO Classification of Central Nervous System Tumors
by: Yaning Wang, et al.
Published: (2023-06-01)

Palliative care for patients with glioma: A recent scientometric analysis of the Web of Science in 2022
by: Zhiyuan Xiao, et al.
Published: (2022-12-01)

Annual Research Progress of Glioma in China in 2022
by: CHEN Wenlin, et al.
Published: (2023-09-01)

Editorial: Impacts of 2021 WHO classification on the precise diagnosis and management of gliomas
by: Xiaopeng Guo, et al.
Published: (2024-02-01)

18F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma
by: Ziren Kong, et al.
Published: (2019-08-01)

Tumor-Treating Fields in Glioblastomas: Past, Present, and Future
by: Xiaopeng Guo, et al.
Published: (2022-07-01)

Multiple brain abscesses caused by Nocardia asiatica: Case report and literature review
by: Shanmu Jin, et al.
Published: (2023-01-01)

Classification of pediatric gliomas based on immunological profiling: implications for immunotherapy strategies
by: Zihao Wang, et al.
Published: (2021-03-01)

Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy
by: Binghao Zhao, et al.
Published: (2022-10-01)

Comprehensive ability evaluation and trend analysis of patients with malignant intracranial tumors in the perisurgery period
by: Yaning Wang, et al.
Published: (2021-11-01)

Investigation of Genetic Determinants of Glioma Immune Phenotype by Integrative Immunogenomic Scale Analysis
by: Binghao Zhao, et al.
Published: (2021-06-01)

Epithelial-mesenchymal transition is the main way in which glioma-associated microglia/macrophages promote glioma progression
by: Xin He, et al.
Published: (2023-03-01)

Thin-Slice Magnetic Resonance Imaging-Based Radiomics Signature Predicts Chromosomal 1p/19q Co-deletion Status in Grade II and III Gliomas
by: Ziren Kong, et al.
Published: (2020-10-01)

Oncolytic viral therapy as promising immunotherapy against glioma
by: Die Hu, et al.
Published: (2023-12-01)

TGIF1 overexpression promotes glioma progression and worsens patient prognosis
by: Baoya Wang, et al.
Published: (2022-12-01)

Diagnosis and Treatment Experience of Multidisciplinary Team for Brain Metastasis in Peking Union Medical College Hospital: A Summary of 159 Cases
by: SHI Yixin, et al.
Published: (2023-03-01)

Secondary gliosarcoma transformed from lower grade glioma: one case report
by: Wei GUO, et al.
Published: (2019-12-01)

IKBKE, a prognostic factor preferentially expressed in mesenchymal glioblastoma, modulates tumoral immunosuppression through the STAT3/PD‐L1 pathway
by: Li Yi, et al.
Published: (2020-07-01)

Indirubin exerts anticancer effects on human glioma cells by inducing apoptosis and autophagy
by: Zhaohui Li, et al.
Published: (2020-09-01)

EVA1B to Evaluate the Tumor Immune Microenvironment and Clinical Prognosis in Glioma
by: Shanqiang Qu, et al.
Published: (2021-04-01)

DTX2 promotes glioma development via regulation of HLTF
by: Ren Li, et al.
Published: (2024-01-01)

Prognostic and Clinic Pathological Value of Cx43 Expression in Glioma: A Meta-Analysis
by: Chao Zhang, et al.
Published: (2019-11-01)

Elevated TAF12 Expression Predicts Poor Prognosis in Glioma Patients: Evidence from Bioinformatic and Immunohistochemical Analyses
by: Xiaodi Guo, et al.
Published: (2022-12-01)

Research Progress About Glioma Stem Cells in the Immune Microenvironment of Glioma
by: Xiangyu Li, et al.
Published: (2021-09-01)

Down-Regulation of PDCD4 Promotes Proliferation, Angiogenesis and Tumorigenesis in Glioma Cells
by: Guo Pin, et al.
Published: (2020-11-01)

Larger 18F-fluoroboronotyrosine (FBY) active volume beyond MRI contrast enhancement in diffuse gliomas than in circumscribed brain tumors
by: Ziren Kong, et al.
Published: (2022-04-01)

lncRNA TRHDE-AS1 Correlated with Genomic Landscape and Clinical Outcome in Glioma
by: Jinxuan Xie, et al.
Published: (2023-05-01)

KLF8 Promotes Temozolomide Resistance in Glioma Cells via β-Catenin Activation
by: Guo Yu, et al.
Published: (2016-04-01)

ROS regulation in gliomas: implications for treatment strategies
by: Yu-Chen Yang, et al.
Published: (2023-12-01)

Decreasing Shortest Path Length of the Sensorimotor Network Induces Frontal Glioma-Related Epilepsy
by: Shengyu Fang, et al.
Published: (2022-02-01)

Cytomegalovirus and Glioblastoma: A Review of the Biological Associations and Therapeutic Strategies
by: Tianrui Yang, et al.
Published: (2022-09-01)

Copper thiosemicarbazones: Antiproliferative action against C6 glioma cells
by: Qiang Fu, et al.
Published: (2014-10-01)